Arthneeti
All Q2 FY27 results →
EH

Entero Healthcare Solutions Ltd

Q2 FY27Retailing

Entero Healthcare Solutions Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹1,665
Market cap₹7.3K Cr
P/E56.2
Updated4 Nov 2026
Read2 min read

Get Entero Healthcare Solutions Ltd's next results in your feed

Entero Healthcare Solutions Ltd Q2 FY27 key numbers

Revenue
Q2FY27 Revenue: Rs. 2,087.1 Cr, a 33% increase YoY from Rs. 1,570.9 Cr in Q2FY26.

As stated in Entero Healthcare Solutions Ltd's Q2 FY27 investor presentation · published 4 Nov 2026. Reported figures, not investment advice.

Based on Entero Healthcare Solutions Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2FY27 Revenue: Rs. 2,087.1 Cr, a 33% increase YoY from Rs. 1,570.9 Cr in Q2FY26 (Page 10). Q2FY27 Financials:.

From Entero Healthcare Solutions Ltd's Q2 FY27 earnings-call transcript · updated 4 Nov 2026.

How did Entero Healthcare Solutions' revenue grow in the September 2026 quarter?

  • Q2FY27 Revenue: Rs. 2,087.1 Cr, a 33% increase YoY from Rs. 1,570.9 Cr in Q2FY26 (Page 10).
  • H1FY27 Revenue: Rs. 4,027.6 Cr, a 35% increase YoY from Rs. 2,974.8 Cr in H1FY26 (Page 10).
  • Organic revenue growth on LFL basis in Q2FY27: 20.0% YoY (Page 7).
  • Reported revenue growth in Q2FY27: 32.9% YoY; Organic growth 18.2% YoY; Inorganic growth 14.7% YoY (Page 7).
  • H1FY27 organic revenue growth on LFL basis: 19.8% YoY; Reported growth: 35.4% YoY (Page 6).
  • Customer and operational scale as of H1FY27: 92,200+ retailers, 2,900+ hospitals, 499 districts covered (Page 13).

2 more points from Entero Healthcare Solutions Ltd's call on revenue

Create a free account to keep reading this call

What happened to Entero Healthcare Solutions' margins in Q2 FY27?

See what Entero Healthcare Solutions Ltd said on profitability & margins — free account, 30 seconds.

What capex is Entero Healthcare Solutions planning?

See what Entero Healthcare Solutions Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Retailing

Ranked on what management guided this quarter

Guidance-ranked
1Rentomojo
Rev 1Mar 3
2V2 Retail
Rev 1Mar 3
3
Rev 2Mar 2
4
Rev 2Mar 2
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Entero Healthcare Solutions raising money or cutting debt?

See what Entero Healthcare Solutions Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Entero Healthcare Solutions' order book?

It focuses primarily on financial performance, operational highlights, revenue growth, margins, cash flow, and business strengths without mentioning these order-related metrics. Key observations: - Emphasis is placed on revenue growth, customer base, warehouses, districts covered, SKUs handled, and relationships with manufacturers. - Financial highlights focus on revenue, profit, margins, cash flows, and balance sheet metrics. - Technology platform and operational efficiencies highlighted but without specific order backlog data.

Entero Healthcare Solutions Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.9K Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Entero Healthcar's management said in earlier quarters

Others in Retailing this season

  • Credo Brands (Q2 FY27)

    189.3 crore . Key investor presentation takeaways from Credo Brands Marketing Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Lenskart Solutions (Q2 FY27)

    Q2 FY27 Revenue:** ₹2,845 Cr, +32.5% YoY (Page 3) . Key investor presentation takeaways from Lenskart Solutions Ltd's Q2 FY27 investor presentation — and how it

  • Sai Silks (Q2 FY27)

    Revenue from operations for Q2 FY 2026-27: ₹434.05 crores (Page 21) . Key investor presentation takeaways from Sai Silks (Kalamandir) Ltd's Q2 FY27 investor pre

  • FSN E-Commerce (Q2 FY27)

    Q2FY27 Revenue from Operations:** Rs 3,006 Cr, up 28% YoY (Page 54, 46) . Key investor presentation takeaways from FSN E-Commerce Ventures Ltd's Q2 FY27 investo

Compare:vs Eternalvs Avenue Supermartsvs Trent

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Entero Healthcare Solutions Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Entero Healthcare Solutions Ltd Q2 FY27 results?

Q2FY27 Revenue: Rs. 2,087.1 Cr, a 33% increase YoY from Rs. 1,570.9 Cr in Q2FY26 (Page 10). Q2FY27 Financials:.

What is Entero Healthcare Solutions Ltd share price analysis?

Entero Healthcare Solutions Ltd currently shows a neutral. The stock trades at a P/E of 56.2 with a market cap of ₹7,254 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Entero Healthcare Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.